LeonaBio, Inc.

Contributing Author

Recent Articles by LeonaBio, Inc.

Sep-03	LeonaBio to Participate in Cantor Global Healthcare Conference 2026 LONA GlobeNewswire
Aug-14	LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update LONA GlobeNewswire
Aug-12	LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology's 4th Summit on Breast Cancer LONA GlobeNewswire
Jun-04	LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit LONA GlobeNewswire
May-27	LeonaBio to Participate in Upcoming Medical and Industry Meetings in June LONA GlobeNewswire
May-07	LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update LONA GlobeNewswire
May-07	LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D. LONA GlobeNewswire
Apr-23	LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer LONA -5.90% GlobeNewswire
Apr-21	Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio's Data LONA GlobeNewswire
Mar-26	LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update LONA +7.20% LONA -7.33% GlobeNewswire
Feb-03	LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer LONA GlobeNewswire